WBA Chart

1 Month

	Date	Diff
	2025-04-22	+1.1 %
Walgreens Boots Alliance (WBA) stock rose by 1.1% due to a favorable environment for financing leveraged buyouts, as banks are continuing to underwrite deals despite recent volatility in the market, indicating confidence in select transactions and companies within defensive sectors.
	2025-04-21	-0.18 %
Walgreens Boots Alliance (WBA) stock decreased by 0.18% following research coverage indicating a "hold" rating and analysts' revisions, including a downgrade to "sell" by Deutsche Bank and lowered price targets from several firms. The stock's decline is attributed to downgrades from analysts, concerns over its performance reflected in negative profit margins, and reduced price targets, signaling a lack of confidence in its near-term prospects. Walgreens Boots Alliance (WBA) stock fell by 0.18% as institutional investors, including Guggenheim Capital, made significant changes to their holdings, with some cutting their positions, which may have contributed to negative market sentiment around the stock.
	2025-04-16	-0.46 %
Walgreens Boots Alliance (WBA) stock declined by 0.46% mainly due to significant changes in institutional investment, including Franklin Resources Inc. reducing its holdings by 71.4%, which might have raised concerns among investors about the company's stability and future prospects.
	2025-04-10	-0.83 %
Walgreens Boots Alliance (WBA) stock decreased by 0.83%, likely due to negative sentiment following multiple price target reductions and sell ratings issued by various financial analysts, alongside a mixed performance in its quarterly earnings report.
	2025-04-09	+1.79 %
Walgreens Boots Alliance (WBA) stock rose 1.79% amid mixed analyst recommendations, primarily due to a positive earnings report that exceeded expectations and highlighted an uptick in revenue. The stock likely went up because the company reported earnings per share of $0.63, surpassing analysts' expectations of $0.53, along with revenue growth of 4.1% compared to the previous year.
	2025-04-08	-1.12 %
Walgreens Boots Alliance (WBA) stock declined by 1.12% as the company prepares to report quarterly earnings, which are anticipated to be lower than expected with earnings projected at 53 cents per share on $38 billion in revenue. Walgreens Boots Alliance (WBA) stock dropped by 1.12% amid heightened market volatility influenced by escalating trade tensions and tariff discussions between the U.S. and China, which have created uncertainty affecting investor sentiment. Walgreens Boots Alliance (WBA) stock dropped by 1.12% after the California Public Employees Retirement System reported a 5% decrease in its holdings of the company, indicating potential concerns from institutional investors regarding the stock's performance. Walgreens Boots Alliance (WBA) stock fell by 1.12% following the company's report of a $2.8 billion loss in its second quarter, largely due to a significant impairment charge connected to its troubled investment in VillageMD clinics, reflecting continued financial struggles amidst a major turnaround effort. The stock decline was primarily driven by the large impairment charge related to their struggling VillageMD investment and ongoing challenges in their U.S. healthcare and retail pharmacy segments. Walgreens Boots Alliance (WBA) stock fell by 1.12% due to concerns about inflation and tariffs raised by Jim Cramer, highlighting a challenging economic environment that may negatively impact consumer purchasing power and corporate performance. Walgreens Boots Alliance, Inc. (WBA) saw a slight decline of -1.12% in its stock despite reporting Q2 2025 results that exceeded earnings and revenue expectations, likely due to broader market reactions or investor concerns despite the positive earnings report.
	2025-04-07	+0.28 %
Walgreens Boots Alliance (WBA) stock rose by 0.28% ahead of its upcoming second-quarter earnings report, where analysts anticipate a significant decline in earnings per share compared to the previous year.
	2025-04-01	-0.09 %
Walgreens Boots Alliance (WBA) shares declined by 0.09% following a decrease in Mitsubishi UFJ Trust & Banking Corp's stake and mixed performance from other institutional investors, reflecting a cautious outlook among analysts, including downgraded ratings and price targets.
	2025-03-31	-0.18 %
Walgreens Boots Alliance (WBA) stock declined by 0.18% due to a class action lawsuit alleging the company engaged in violations of federal law regarding prescription medication, which negatively affected investor confidence and revealed the potential for further regulatory scrutiny and financial liability.
	2025-03-28	+0.27 %
Walgreens Boots Alliance (WBA) stock increased by 0.27% amid an announcement about a class action lawsuit involving investor rights, suggesting that some investors may have viewed the litigation as a potential opportunity for compensation or liability resolution. Walgreens Boots Alliance (WBA) stock increased by 0.27%, likely due to investor optimism regarding improvements in retail operations and strategies to combat shoplifting without adversely affecting sales.
	2025-03-27	+0.54 %
Walgreens Boots Alliance (WBA) stock rose by 0.54% as multiple research analysts provided varying ratings and price target revisions, which likely contributed to investor optimism following the company’s strong quarterly earnings report that exceeded analyst expectations.
	2025-03-26	-0.18 %
Walgreens Boots Alliance (WBA) stock fell by 0.18% following the announcement of a class action lawsuit against the company and its executives for alleged violations of federal securities laws, amid concerns over ongoing compliance issues related to its prescription drug practices and a recent civil complaint from the DOJ regarding unlawful dispensing of controlled substances.
	2025-03-25	-0.27 %
Walgreens Boots Alliance (WBA) stock fell by 0.27% amid a class action lawsuit alleging the company made false statements about its compliance with prescription medication regulations, which resulted in the U.S. Department of Justice filing a civil complaint against it for dispensing unlawful prescriptions. Walgreens Boots Alliance (WBA) stock fell by 0.27% possibly due to revelations from a class action lawsuit alleging that the company misled investors about its regulatory compliance and financial practices concerning prescription medications, leading to heightened legal and reputational risks. Walgreens Boots Alliance (WBA) stock fell by 0.27% due to a combination of upcoming quarterly earnings expectations and mixed analyst ratings, which indicate uncertainty in the company’s performance and outlook.
	2025-03-24	+0.45 %
Walgreens Boots Alliance (WBA) stock rose by 0.45% last night, likely due to increased institutional investments and positive quarterly earnings that surpassed analyst expectations. The article discusses an ongoing class action lawsuit against Walgreens Boots Alliance, Inc. for alleged securities fraud, but despite this legal issue, WBA stock experienced a 0.45% increase. The increase in Walgreens Boots Alliance (WBA) stock may be attributed to market reactions that could be driven by broader investor sentiment, potential strategic company developments, or overall performance trends that outweigh the concerns related to the lawsuit.
	2025-03-21	-0.18 %
Walgreens Boots Alliance (WBA) stock is down by 0.18% due to pressure on pharmacy reimbursement rates impacting cash flows, concerns over mounting debt and potential legal penalties, and reduced gross margins leading to negative free cash flow expectations.
	2025-03-20	-0.36 %
Walgreens Boots Alliance (WBA) stock was down 0.36% due to ongoing concerns stemming from a class action lawsuit alleging that the company failed to disclose violations of federal law related to prescription medication dispensing, which could expose it to regulatory scrutiny and financial liability.
	2025-03-19	-0.09 %
Walgreens Boots Alliance (WBA) stock decreased by 0.09% due to concerns over a class action lawsuit alleging the company made misleading statements and violated federal laws regarding prescription medications, leading to increased regulatory scrutiny and a significant drop in stock price following the announcement of a civil complaint by the U.S. Department of Justice. Walgreens Boots Alliance (WBA) stock fell by 0.09% amidst mixed analyst ratings and reduced price targets from several research firms, indicating investor concerns over the company's future performance.
	2025-03-18	-0.8 %
Walgreens Boots Alliance (WBA) stock fell 0.8% after recent analysts’ reports provided a mixed outlook, with several institutions lowering their price targets and maintaining "hold" or "sell" ratings, indicating investor caution amidst a lack of strong bullish sentiment.
	2025-03-14	-0.27 %
Walgreens Boots Alliance (WBA) stock declined by 0.27% following the disclosure of Representative Julie Johnson's recent sale of shares, which may have raised concerns among investors about insider sentiment and confidence in the company's prospects.
	2025-03-13	+0.54 %
Walgreens Boots Alliance's stock rose by 0.54% due to its collaboration with Palantir Technologies, which is enhancing efficiency in American manufacturing and defense, signaling strong potential for growth in its commercial business. The article discusses a class action lawsuit against Walgreens Boots Alliance (WBA) regarding undisclosed regulatory violations and misleading statements to investors, while noting that WBA's stock rose by 0.54% likely due to investor optimism surrounding potential legal outcomes or market conditions.
	2025-03-12	-0.09 %
Walgreens Boots Alliance (WBA) stock experienced a minor decrease of 0.09% due to analysts downgrading the company's ratings and target prices, which raises concerns about its financial performance and market positioning. Walgreens Boots Alliance (WBA) stock declined by 0.09%, with analysts predominantly rating it as a "Reduce" and adjusting target prices downward due to concerns over profitability and overall market conditions. Walgreens Boots Alliance (WBA) stock fell by 0.09% due to an investigation by Halper Sadeh LLC into the company's proposed sale to Sycamore Partners, raising concerns regarding potential violations of federal securities laws and fiduciary duties to shareholders.
	2025-03-11	-0.62 %
Walgreens Boots Alliance (WBA) stock was down by 0.62% due to an ongoing investigation by Halper Sadeh LLC into potential violations of federal securities laws and breaches of fiduciary duties related to the proposed sale of the company to Sycamore Partners, which may have raised concerns among investors. Walgreens Boots Alliance (WBA) stock declined by 0.62% amidst a class action lawsuit alleging that the company violated federal laws in prescription medication practices, resulting in increased regulatory scrutiny and civil liability. Walgreens Boots Alliance (WBA) stock fell by 0.62%, partly due to Keybank National Association OH decreasing its stake by 34.3% and mixed ratings from analysts, indicating a lack of strong investor confidence. Walgreens Boots Alliance (WBA) stock recently declined by 0.62% as a result of a class action lawsuit alleging the company misled investors regarding its compliance with opioid prescription regulations, compounded by a civil complaint from the DOJ accusing Walgreens of improperly dispensing controlled substances over several years. Walgreens Boots Alliance (WBA) stock decreased by 0.62% amid mixed analyst ratings and a debt burden despite recent increases in institutional holdings. The decline in the stock may be attributed to concerns over its negative net margin, recent downgrade from Deutsche Bank, and overall market sentiment as reflected by its mixed ratings from analysts.
	2025-03-07	+7.45 %
Walgreens Boots Alliance (WBA) stock surged almost 7% on news of its agreement to go private in a deal worth up to $23.7 billion with Sycamore Partners, following months of negotiations. Walgreens Boots Alliance (WBA) stock rose 7.45% following news of a finalized deal to go private with Sycamore Partners, valued at up to $23.7 billion, sparking investor optimism about the company's future outside of public market pressures. Walgreens Boots Alliance (WBA) stock rose 7% after the company announced a $10 billion acquisition by Sycamore Partners, marking a shift to a privately held entity. The increase in stock price is attributed to the acquisition deal, which offered investors a cash payout of $11.45 per share. Walgreens Boots Alliance (WBA) stock saw a 7.45% increase following positive movements from institutional investors, including significant stakes purchased by firms like SVB Wealth LLC and State Street Corp, coupled with better-than-expected quarterly earnings that surpassed analyst estimates. Walgreens Boots Alliance (WBA) stock rose 7.5% due to an agreement for the pharmacy and drug store chain to be acquired by private equity firm Sycamore Partners, which will take it private and provide more operational flexibility. Walgreens Boots Alliance (WBA) stock rose 7.45% after the company announced an agreement to be acquired by private equity firm Sycamore Partners for approximately $10 billion. The increase is attributed to the positive market reaction to the acquisition news. Walgreens Boots Alliance (WBA) stock surged by 7% after the company announced a $10 billion acquisition deal with Sycamore Partners, transitioning to a privately held company with a purchase price of $11.45 per share in cash.
	2025-03-06	-1.4 %
Walgreens Boots Alliance (WBA) shares were down 1.4% despite announcing a deal to be acquired by Sycamore Partners, likely due to market reactions to the acquisition news indicating investor skepticism or profit-taking. Walgreens Boots Alliance (WBA) stock fell by 1.4% following the announcement that it will be acquired by Sycamore Partners for $10 billion at a price of $11.45 per share, which reflects a significant drop in value for the company over the years due to increased competition and operational challenges. The decline in WBA stock can be attributed to the market's reaction to the acquisition offer, which highlights the company's decreased valuation compared to its previous worth and ongoing concerns about its debt and performance. Walgreens Boots Alliance (WBA) stock declined by 1.4% following ongoing concerns reflected in a series of downgrades from analysts, coupled with a weaker than expected earnings outlook, despite some positive quarterly performance indicators. Walgreens Boots Alliance (WBA) stock decreased by 1.4% due to negative sentiment from analysts, with several lowering their price targets and ratings for the company. Walgreens Boots Alliance (WBA) stock recently fell by 1.4% amid news of its impending takeover by Sycamore Partners for over $10 billion, which is seen as a move to stabilize the company after years of losses and challenges, particularly from unsuccessful expansions in healthcare services. The decline in stock price reflects investor concerns over the company's financial health and the ongoing operational struggles that led to the buyout offer. Walgreens Boots Alliance (WBA) stock fell 1.4% due to allegations of the company engaging in regulatory violations regarding the dispensation of prescription medication, which poses risks of further scrutiny and impacts the sustainability of its revenues.
	2025-03-04	+5.65 %
Walgreens Boots Alliance (WBA) stock rose 5.65% due to reports that the company is nearing a $10 billion go-private deal with Sycamore Partners, which plans to acquire shares at prices between $11.30 and $11.40. Walgreens Boots Alliance (WBA) stock rose by 5.65% as it approaches a nearly $10 billion deal with private-equity firm Sycamore Partners to take the struggling drugstore chain private, with a proposed share price of $11.30 to $11.40. Walgreens Boots Alliance (WBA) stock rose 5.65% following reports that the company is close to a $10 billion deal with Sycamore Partners to go private. Walgreens Boots Alliance (WBA) stock rose 5.65% following a report indicating that the company is close to finalizing a deal with private-equity firm Sycamore Partners. Walgreens Boots Alliance (WBA) stock rose by 5.65% after the company outperformed earnings expectations with a quarterly report showing higher-than-anticipated earnings and revenue, alongside significant institutional investor interest in increasing their stakes in the company.
	2025-02-27	+1.72 %
Walgreens Boots Alliance (WBA) stock rose by 1.72% as institutional investors, including Ieq Capital LLC, significantly increased their holdings in the company, indicating growing confidence in its financial performance following a recent earnings report that exceeded analyst expectations. Walgreens Boots Alliance (WBA) stock rose 1.72% after Wolfe Research upgraded its rating to "hold" amidst mixed feedback from other analysts, which has sparked interest from institutional investors. Walgreens Boots Alliance (WBA) stock rose by 1.72%, attributed to factors such as positive quarterly earnings exceeding analyst expectations and an increase in the target price set by analysts, despite some hedge funds reducing their stakes in the company.
	2025-02-26	-2.99 %
Walgreens Boots Alliance (WBA) stock fell by 2.99% due to allegations of widespread regulatory violations regarding the dispensation of prescription medications, which raised concerns about the company's sustainability and potential legal repercussions.
	2025-02-25	+5.18 %
Walgreens Boots Alliance (WBA) stock rose 5.18% following the announcement of a class action lawsuit against the company alleging violations of the Securities Exchange Act, which may have sparked investor optimism about potential resolutions or legal settlements.
	2025-02-24	+6.5 %
Walgreens Boots Alliance (WBA) stock rose 6.5% following the announcement of a class action lawsuit regarding allegations of misleading statements made by the company about regulatory compliance and the sustainability of its revenues from prescription medications during a specific class period.
	2025-02-19	-2.44 %
Walgreens Boots Alliance (WBA) stock declined by 2.44% due to mixed sentiment among institutional investors, with some trimming their stakes despite the company reporting better-than-expected earnings and revenue growth, and various analysts adjusting their price targets.
	2025-02-18	+14.02 %
The stock of Walgreens Boots Alliance (WBA) saw a significant increase of 14.02% amid a class-action lawsuit concerning alleged securities fraud related to the company's management of controlled substances, indicating investors may be responding positively to legal developments or other news surrounding the company.
	2025-02-14	-0.51 %
Walgreens Boots Alliance (WBA) stock fell by 0.51% following mixed market reactions to its recent earnings report, in which it exceeded revenue expectations but posted a decline in earnings per share compared to the previous year, and faced downgrades in its target prices from several analysts. The stock's decline could be attributed to ongoing market concerns about its profitability despite recent revenue growth, along with shifting analyst sentiments reflecting cautious outlooks. The Walgreens Boots Alliance (WBA) stock declined by 0.51% primarily due to concerns surrounding the significant selling activity of executives, which can signal potential issues within the company.
	2025-02-13	+2.96 %
The Walgreens Boots Alliance (WBA) stock rose 2.96% as the company faces a class action lawsuit alleging securities violations, but the overall sentiment around the stock may improve as investors look for potential recovery opportunities after a previous drop in response to legal challenges. Walgreens Boots Alliance (WBA) stock rose 2.96% amid a class action lawsuit alleging federal securities law violations by the company, which followed recent negative news regarding its compliance practices, though the recent price increase is not directly linked to this lawsuit but may reflect market corrections or investor sentiment following the announcement. Walgreens Boots Alliance (WBA) stock rose by 2.96% due to several large investors increasing their holdings and the company reporting better-than-expected quarterly earnings, driving positive sentiment among investors. Walgreens Boots Alliance (WBA) stock rose 2.96% last night, primarily due to a mix of institutional buying interest, positive quarterly earnings that exceeded analysts' expectations, and a general shift in market sentiment regarding the company's financial outlook despite some recent reductions in price targets from analysts.
	2025-02-12	+1.18 %
Walgreens Boots Alliance (WBA) stock rose by 1.18% as the company announced plans to close five underperforming locations in Southern California, part of a broader downsizing strategy aimed at streamlining operations and addressing financial challenges. The increase in stock value may be attributed to investors' perception that the store closures and restructuring efforts will help improve the company's financial situation and operational efficiency in response to significant losses and declining sales. Walgreens Boots Alliance (WBA) stock rose by 1.18% after shareholders were informed about a class action lawsuit alleging that the company misled investors regarding its compliance with federal regulations, potentially leading to increased scrutiny and liability, which could have been contributing factors to investor interest and stock movement. Walgreens Boots Alliance (WBA) stock rose by 1.18% amid a class action lawsuit announcement, which may indicate investor optimism regarding potential compensation for those affected by the alleged failures in regulatory compliance and misrepresentation of the company's practices.
	2025-02-11	-6.12 %
Walgreens Boots Alliance (WBA) stock fell by 6.12% due to a securities fraud class action lawsuit alleging that the company made misrepresentations regarding its efforts to prevent controlled substance diversion.
	2025-02-10	-1.48 %
Walgreens Boots Alliance (WBA) stock fell by 1.48% after abrdn plc reduced its stake in the company by 7.6%, raising concerns among investors amid mixed ratings and lowered price targets from various analysts, which may have influenced bearish sentiment.
	2025-02-07	+0.7 %
Walgreens Boots Alliance (WBA) stock rose 0.7% following the announcement of a $300 million share sale in drug distributor Cencora to aid in debt repayment and support its financial turnaround strategy. The stock went up because the proceeds from the share sale will help the company address upcoming debt maturities while they work on a broader long-term turnaround plan. Walgreens Boots Alliance (WBA) stock rose by 0.7% amid the announcement of a class action lawsuit concerning potential undisclosed violations of federal law related to prescription medication dispensation, which may indicate increased investor interest or speculation regarding the outcome of the lawsuit. Walgreens Boots Alliance (WBA) stock rose by 0.7% likely due to increased investment from notable institutional investors, such as Greenleaf Trust and State Street Corp, as well as a positive quarterly earnings report that exceeded expectations.
	2025-02-06	-0.69 %
Walgreens Boots Alliance (WBA) stock fell by 0.69% as a result of a class action lawsuit alleging that the company and its executives engaged in misleading practices and violated federal law regarding prescription medications, a situation exacerbated by a recent announcement from the U.S. Department of Justice about the company dispensing unlawful prescriptions. Walgreens Boots Alliance (WBA) stock fell by 0.69% due to ongoing legal issues and allegations of regulatory violations related to the dispensation of prescription medications, which have raised concerns about the company's compliance, revenues, and potential liabilities. Walgreens Boots Alliance (WBA) stock decreased by 0.69% following a series of mixed analyst opinions and sluggish investor sentiment despite positive earnings results, reflecting uncertainty in the company's future performance.
	2025-02-04	+1.33 %
Walgreens Boots Alliance (WBA) stock rose 1.33% as it appears investors may be reacting positively to recent legal developments or market conditions despite ongoing class action allegations regarding misleading investor information about its opioid prescription practices.
	2025-02-03	-5.06 %
Walgreens Boots Alliance (WBA) stock fell by 5.06% following a series of downgrades from multiple equity research firms, alongside negative sentiment from institutional investors reducing their stakes in the company. Walgreens Boots Alliance (WBA) stock fell by 5.06% following the announcement of a securities class action lawsuit alleging that the company made false representations regarding its efforts to prevent the diversion of controlled substances. Walgreens Boots Alliance (WBA) stock fell 5.06% due to an investigation by the Rosen Law Firm over allegations that the company misled investors about its business practices, which coincided with a DOJ lawsuit claiming Walgreens knowingly filled millions of invalid prescriptions for controlled substances. Walgreens Boots Alliance (WBA) stock fell by 5.06% following a downgrade of its price target from $13.00 to $12.00 by Truist Financial, alongside other analysts' negative reviews, indicating a lack of confidence in the stock's future performance.
	2025-01-31	-10.3 %
Walgreens Boots Alliance (WBA) stock dropped by 10.3% due to reduced holdings by several institutional investors amidst a mixed sentiment from analysts regarding the company's performance and future outlook. Walgreens Boots Alliance (WBA) stock fell by 10.3% after the company announced it would suspend its 92-year-long dividend in an effort to improve its balance sheet. Walgreens Boots Alliance (WBA) stock fell 8.8% after the company announced the suspension of its dividend, breaking a long-standing streak of quarterly payouts to shareholders that had lasted over 90 years. Walgreens Boots Alliance (WBA) stock experienced a significant drop of over 15% following a brief surge earlier in the month, as investors reacted to ongoing concerns about the company's future performance despite initially positive quarterly results. The stock's decline can be attributed to lingering investor uncertainty and market volatility, indicating that the earlier positive momentum may have been short-lived or overshadowed by broader concerns about the company's long-term prospects. Walgreens Boots Alliance (WBA) stock fell 10.3% after the company suspended its quarterly dividend to conserve cash for addressing legal challenges and refinancing debt as part of its efforts to stabilize its finances. Walgreens Boots Alliance (WBA) stock dropped 10.3% due to recent earnings reports indicating a decline in profit margins despite revenue growth, alongside mixed analyst ratings and adjustments in institutional investments. Walgreens Boots Alliance (WBA) stock dropped 10.3% following the announcement of a lawsuit by the U.S. Department of Justice, which alleged that Walgreens had knowingly filled millions of illegitimate prescriptions, leading to investor concerns over misleading business information.
	2025-01-30	+1.87 %
Walgreens Boots Alliance (WBA) stock rose 1.87% due to positive quarterly earnings results that exceeded analysts' expectations, alongside increased institutional investment in the company. Walgreens Boots Alliance (WBA) stock rose by 1.87%, driven by recent positive earnings results that exceeded analyst estimates and an increase in institutional investments in the company, particularly notable stakes raised by several hedge funds. Walgreens Boots Alliance (WBA) stock rose by 1.87% due to significant increases in holdings by various institutional investors and hedge funds during the recent quarters, reflecting growing confidence in the company's potential despite mixed analyst ratings. Walgreens Boots Alliance (WBA) stock rose by 1.87% amidst a significant increase in anticipated retail store closures in the U.S., which has prompted a shift toward cost-cutting measures and store optimization strategies for many retailers, including WBA.
	2025-01-28	-3.97 %
Walgreens Boots Alliance (WBA) stock fell by 3.97% due to an investigation by Rosen Law Firm into allegations that the company issued misleading business information, which surfaced following a lawsuit by the Department of Justice claiming Walgreens filled millions of prescriptions without a legitimate medical purpose.
	2025-01-24	+1.11 %
Walgreens Boots Alliance (WBA) stock rose by 1.11% despite the company being listed among major retailers expected to close stores this year, reflecting a broader context of increasing stock market performance amidst significant retail closures due to competition from fast-growing online retailers like Temu and Shein, which highlight challenges traditional retailers face. The increase in WBA's stock may be attributed to broader market trends or investor optimism rather than direct performance, reflecting potential future strategies for adaptation in a changing retail landscape. Walgreens Boots Alliance (WBA) stock rose by 1.11% due to strong institutional ownership, favorable analyst ratings indicating a higher potential upside compared to competitor Guardian Pharmacy Services, and overall positive comparisons in various financial metrics.
	2025-01-23	+1.03 %
Walgreens Boots Alliance (WBA) stock rose 1.03% as institutional investors, including Ameritas Advisory Services LLC and HB Wealth Management LLC, significantly increased their stakes in the company during the 4th quarter, alongside positive earnings results that exceeded analyst expectations, fueling investor confidence.
	2025-01-22	+2.2 %
Walgreens Boots Alliance (WBA) stock rose 2.2% despite regulatory troubles, as investors may be optimistic about the company's prospects or recent market trends. Walgreens Boots Alliance (WBA) stock rose by 2.2% recently, likely due to continued optimism from Jim Cramer regarding the strength of the labor market and its potential positive impact on business performance, coupled with a perception that the company's management is effectively addressing challenges despite previous struggles with reimbursement issues and reduced consumer spending. The article discusses an investigation by the Rosen Law Firm into Walgreens Boots Alliance (WBA) due to allegations of misleading business information following a DOJ lawsuit, despite the stock rising 2.2% the previous night, possibly indicating investor optimism or rebound efforts after a recent 9% drop due to negative news.
	2025-01-21	-9.19 %
Walgreens Boots Alliance (WBA) stock fell by 9.19% as it continues to receive negative ratings from analysts, with a majority recommending a "reduce" rating due to concerns about its financial performance and lowered price targets from various brokerage firms. Walgreens Boots Alliance (WBA) stock dropped by 9.19% following a lawsuit filed by the Department of Justice, which accused the company of dispensing millions of unlawful prescriptions.
	2025-01-17	-3.17 %
Walgreens Boots Alliance (WBA) stock dropped by 3.17% following the announcement of a lawsuit by the U.S. Department of Justice, accusing the company of dispensing millions of unlawful prescriptions and violating the Controlled Substances Act.
	2025-01-16	+3.19 %
Walgreens Boots Alliance (WBA) stock increased by 3.19% due to signs of progress in its long-anticipated turnaround, marking its biggest move in four decades amidst previously low investor sentiment.
	2025-01-15	+2.37 %
Walgreens Boots Alliance (WBA) stock rose by 2.37% following the company's better-than-expected fiscal first-quarter results, driven by strong earnings amid strategic cost-reduction initiatives and plans to close underperforming stores, prompting increased investor confidence. Walgreens Boots Alliance (WBA) stock rose by 2.37% as institutional investors, including Moody National Bank and State Street Corp, significantly increased their holdings during the last quarter, which reflects growing confidence in the company's financial performance and future prospects. Walgreens Boots Alliance (WBA) stock rose by 2.37% following CEO Tim Wentworth's acknowledgment during the earnings call that locking up merchandise to prevent theft has negatively impacted sales, prompting potential changes to improve customer experience and address inventory loss. Walgreens Boots Alliance (WBA) stock rose 2.37% following an increase in its target price by Bank of America, although it still holds an "underperform" rating, suggesting mixed investor sentiment; the stock's upward movement could be attributed to a positive earnings report that exceeded expectations, as well as growing institutional interest.
	2025-01-14	+2.86 %
Walgreens Boots Alliance (WBA) stock rose 2.86% following an upgrade in its price objective from Evercore ISI from $9.00 to $12.00, amid a positive earnings report that exceeded analyst expectations and increased revenue, despite several mixed ratings from other brokerages. Walgreens Boots Alliance (WBA) stock rose by 2.86% following a positive earnings report highlighting a 7.5% sales increase and initial signs of a turnaround under CEO Tim Wentworth. The stock increase can be attributed to investor optimism about the company's recovery strategy, despite a reported quarterly loss due to ongoing restructuring efforts. Walgreens Boots Alliance (WBA) stock rose 2.86% due to strong Q1 results that surpassed revenue and earnings expectations, indicating robust growth in its U.S. Retail Pharmacy and Healthcare sectors.
	2025-01-13	+1.19 %
Walgreens Boots Alliance (WBA) stock rose 1.19% following the company's better-than-expected fiscal Q1 2025 results, signaling a rebound from a challenging 2024 where the stock fell over 60%. Walgreens Boots Alliance (WBA) stock rose 1.19% following the announcement of better-than-expected fiscal Q1 2025 results, signaling a rebound from a difficult 2024 where the stock lost over 60% of its value. Walgreens Boots Alliance (WBA) stock rose 27.5% on January 10, 2024, following recent positive market sentiment, yet it remains down 64% from the previous year; the surge reflects investor optimism about potential recovery and improvements in performance.
	2025-01-10	+27.55 %
Walgreens Boots Alliance (WBA) stock surged nearly 30% following a first-quarter profit beat that indicated successful turnaround efforts for the healthcare company, amidst a backdrop of a broader stock market decline driven by a strong jobs report raising concerns about sustained higher interest rates. Walgreens Boots Alliance (WBA) stock surged by 27.55% following a strong report of first-quarter sales that reached $39.46 billion, exceeding expectations and indicating growth across all segments. The increase in stock price is primarily attributed to the company's better-than-expected financial performance and positive outlook. Walgreens Boots Alliance (WBA) stock surged nearly 30% following a strong first-quarter earnings report that exceeded Wall Street estimates, signaling successful turnaround efforts for the healthcare company. Walgreens Boots Alliance (WBA) stock surged 27.55% following the company's better-than-expected fiscal first quarter results, which included adjusted earnings per share of 51 cents and a revenue increase of 7.5%, despite reporting a $265 million loss primarily due to costs associated with closing U.S. stores and restructuring efforts. Walgreens Boots Alliance (WBA) stock surged over 25% to $11.53 per share after the company reported strong first-quarter fiscal 2025 results, reaching its highest level since August 2024. The increase in WBA's stock is attributed to better-than-expected financial results for the first quarter, indicating improved performance and investor confidence. Walgreens Boots Alliance Inc. stock surged 10% after the company reported a loss but exceeded adjusted earnings estimates and committed to ongoing turnaround efforts. The stock likely rose due to investor optimism about its ability to improve performance despite the reported losses. Walgreens Boots Alliance (WBA) stock saw a significant increase of 27.55% due to positive quarterly earnings results that surpassed analysts' expectations, increased revenue, and recent institutional investments in the company.
	2025-01-06	-0.32 %
Walgreens Boots Alliance (WBA) stock fell by 0.32% following a significant reduction in shares held by Central Pacific Bank Trust Division and various analyst downgrades on the company's stock price targets. Walgreens Boots Alliance (WBA) stock declined by 0.32% last night amidst a broader trading environment where investors were anticipating critical economic data and corporate earnings reports. The drop in stock price could be attributed to concerns surrounding the company's upcoming earnings and the general volatility in the stock market as investors navigate economic uncertainties.
	2024-12-31	+0.76 %
Despite a generally down market, Walgreens Boots Alliance (WBA) saw a 0.76% increase in its stock value, amid the backdrop of significant annual gains for other stocks driven by strong performances in the tech sector and changes in economic policy under the new political leadership.
	2024-12-30	-3.74 %
Walgreens Boots Alliance (WBA) stock fell by 3.74% following a consensus "Reduce" rating from analysts, with multiple price target cuts reflecting concerns over the company's financial performance and market outlook. The stock decline is attributed to negative analyst sentiments, reduced price targets, and ongoing concerns regarding the company’s profitability metrics, including its negative net margin and decreased earnings per share compared to the previous year.
	2024-12-27	-0.62 %
Walgreens Boots Alliance (WBA) stock fell by 0.62% due to negative market sentiment, impacted by several research firms reducing their target prices and overall weak financial performance indicators, including a negative net margin and a low PE ratio.
	2024-12-26	+5.33 %
Walgreens Boots Alliance (WBA) stock rose by 5.3%, the biggest gain among S&P 500 stocks, due to a positive market sentiment surrounding the healthcare sector, amidst a mixed finish for major stock indexes as tech stocks declined.
	2024-12-24	-1.18 %
Walgreens Boots Alliance (WBA) stock fell by 1.18% recently, despite earlier hopes for a potential buyout deal, indicating ongoing investor uncertainty and challenges facing the company. Walgreens Boots Alliance (WBA) stock fell by 1.18% after a brief rise following news of a potential buyout deal, as investors continue to seek positive developments to lift the company's struggling stock price. The decline may be attributed to ongoing concerns over the company's performance and the overall market reaction to news that is not fully concrete.
	2024-12-23	-2.62 %
Walgreens Boots Alliance (WBA) stock fell by 2.62% due to a significant reduction in institutional holdings and negative adjustments to its price targets by several brokerages, which reflects a lack of confidence in the company's financial performance amid ongoing operational challenges.
	2024-12-19	-3.61 %
Walgreens Boots Alliance (WBA) stock fell by 3.61% amid ongoing adjustments by institutional investors and concerns about analyst ratings, including several downward revisions to price targets, indicating broader market skepticism about the company's future performance.
	2024-12-17	-2.06 %
Walgreens Boots Alliance (WBA) stock fell by 2.06% after Quantinno Capital Management LP significantly reduced its stake by 75.8% in the third quarter, highlighting uncertainty among investors regarding the company's performance amidst mixed analyst ratings and recent financial results.
	2024-12-16	-2.02 %
Walgreens Boots Alliance (WBA) stock fell by 2.02% due to ongoing investor concerns stemming from its significant decline of 57% over the year, compounded by recent earnings losses, plans to close stores, and speculation about potential acquisition by private equity. Walgreens Boots Alliance (WBA) stock fell by 2.02% due to institutional investors adjusting their holdings and multiple analysts lowering their price targets for the stock, reflecting a generally negative sentiment about its performance and outlook.
	2024-12-10	+17.74 %
Walgreens Boots Alliance (WBA) stock jumped 17.74% following reports that the company is in talks with private equity firm Sycamore Partners for a potential sale, which investors see as a positive step after the company's struggles due to past investments. Walgreens Boots Alliance Inc. stock rose by 17.74% following reports that the company is in discussions to sell itself to private equity firm Sycamore Partners, causing a surge in investor interest. Walgreens Boots Alliance (WBA) stock surged 18% following reports of potential acquisition talks with private equity firm Sycamore Partners, despite the company's ongoing struggles and plans to close 1,200 stores over three years. The stock increase is attributed to the news of the acquisition discussions, which likely raised investor optimism about the company's future prospects. Shares of Walgreens Boots Alliance (WBA) surged 20% due to speculation about a potential buyout by a private equity firm, which typically results in stock prices rising above their current market value. Walgreens Boots Alliance Inc. stock surged by 17.74% following news that the company is in talks to be acquired by private-equity firm Sycamore Partners. Walgreens Boots Alliance (WBA) stock surged by 17.74% following news that Sycamore Partners is in talks to acquire the struggling drugstore chain, which ignited investor optimism about a potential private equity deal. The stock's rise can be attributed to expectations surrounding the acquisition talks, as such deals often provide a lifeline for struggling companies, especially considering WBA's recent significant losses and ongoing challenges in the retail sector. Walgreens Boots Alliance (WBA) stock surged by 17.74% due to significant interest from institutional investors, including a notable purchase from Benjamin Edwards Inc. and increases in holdings by other large funds, which reflects growing confidence in the company's financial performance after it reported earnings that exceeded analyst expectations.
	2024-12-09	+3.39 %
Walgreens Boots Alliance (WBA) stock rose 3.39% due to increased institutional investment, including a significant stake increase by Hilltop Holdings Inc., alongside better-than-expected quarterly earnings and revenue which beat analyst estimates. Walgreens Boots Alliance (WBA) stock rose 3.39% due to increased institutional investment, as evidenced by a 17.0% stake increase from the Public Sector Pension Investment Board and similar actions from other hedge funds, indicating growing confidence in the company’s financial performance and future prospects.
	2024-12-06	+1.06 %
Walgreens Boots Alliance (WBA) stock rose by 1.06% due to positive earnings results that exceeded analyst expectations and an upcoming dividend announcement, which increased investor confidence despite mixed ratings from analysts.
	2024-12-04	-2.35 %
Walgreens Boots Alliance (WBA) stock fell by 2.35% following a series of downgraded price targets and ratings by multiple analysts, indicating weak market sentiment towards the company's performance.
	2024-12-03	-0.33 %
Walgreens Boots Alliance (WBA) stock fell by 0.33% due to ongoing concerns about prescription drug fraud that are affecting pharmacies nationwide, particularly with the misuse of electronic health records (EHRs) and e-prescribing systems, along with Walgreens' consideration to sell parts of its struggling investment in VillageMD amidst profitability issues.
	2024-12-02	-0.44 %
Walgreens Boots Alliance (WBA) stock declined by 0.44% primarily due to market volatility and changes in institutional holdings, despite reporting earnings that surpassed analysts' expectations. Walgreens Boots Alliance (WBA) stock declined by 0.44% as it continues to face negative sentiment from analysts, with an average rating of "Reduce" and multiple significant downward revisions of price targets from various firms, indicating concerns over its financial performance and market position.
	2024-11-29	-0.44 %
Walgreens Boots Alliance (WBA) stock fell by 0.44% last night, amidst mixed institutional investor activity and varying analyst recommendations which reflect cautious sentiment about the company's future performance. The decline in stock price may be due to various factors including recent downgrades and uncertainty reflected by analysts’ lowered price targets, combined with a negative net margin and a mixed financial outlook.
	2024-11-27	+3.78 %
Walgreens Boots Alliance (WBA) stock rose 3.78% due to positive quarterly earnings that exceeded analysts' expectations and news of dividend declarations, alongside active trading and modifications in institutional investors' holdings. Walgreens Boots Alliance (WBA) stock rose 3.78% last night following positive earnings results that exceeded analysts' expectations, a substantial year-over-year revenue increase, and the announcement of a quarterly dividend, which contributed to investor optimism.
	2024-11-25	+4.62 %
Walgreens Boots Alliance (WBA) stock rose 4.62% following significant new investments by institutional investors and positive quarterly earnings results that exceeded analyst estimates, contributing to an overall favorable sentiment around the company.
	2024-11-22	+4.34 %
Walgreens Boots Alliance (WBA) stock rose 4.34% due to positive quarterly earnings results exceeding consensus estimates and a recent dividend announcement, despite mixed evaluations from analysts and adjustments to institutional holdings.
	2024-11-21	+0.73 %
Walgreens Boots Alliance (WBA) stock rose by 0.73% due to its strong dividend yield and solid financial performance, contributing to investor confidence, especially in comparison to other dividend-paying stocks like Altria. Walgreens Boots Alliance (WBA) stock rose 0.73% likely due to positive quarterly earnings results exceeding analyst expectations and an increase in revenue, as well as ongoing interest from institutional investors despite some hedge funds reducing their positions.
	2024-11-19	-4.27 %
Walgreens Boots Alliance (WBA) shares fell by 4.27% due to a combination of negative analyst ratings, downgraded price targets, and mixed financial performance, including a decrease in earnings per share compared to the previous year.
	2024-11-18	+2.12 %
Walgreens Boots Alliance (WBA) stock increased by 2.12% following a period of decline fueled by backlash over a controversial Christmas advert featuring gender-inclusive pronouns. The recent uptick could indicate a temporary market correction or a response to underlying factors unrelated to the controversy, despite significant criticism and past stock performance challenges. Walgreens Boots Alliance (WBA) stock rose 2.12% recently, partly due to positive quarterly earnings that exceeded analysts' expectations, as well as upcoming dividends for shareholders. Walgreens Boots Alliance (WBA) stock rose 2.12% amid ongoing online backlash against its U.K. subsidiary Boots' holiday ad that featured gender-inclusive pronouns, despite facing criticism and a trending boycott hashtag. The stock increase could be attributed to market reactions rather than a direct correlation with the ad controversy. Walgreens Boots Alliance (WBA) stock rose by 2.12% after the company reported stronger-than-expected quarterly earnings and revenue, surpassing analysts' estimates, and as it declared a substantial dividend, attracting investor interest.
	2024-11-15	-3.75 %
Walgreens Boots Alliance (WBA) stock dropped by 3.75% due to a combination of reduced price estimates by multiple analysts and the company's ongoing struggles reflected in its declining earnings per share and net margins, despite reporting better-than-expected earnings and revenue for the last quarter.
	2024-11-14	-2.44 %
Walgreens Boots Alliance (WBA) stock fell by 2.44% due to a combination of analysts adjusting their price targets downwards and the stock’s underperformance relative to past earnings results, despite a positive earnings report for the last quarter. Walgreens Boots Alliance (WBA) stock fell by 2.44% following a significant reduction in its shares held by Amalgamated Bank and a series of downward adjustments in price targets by various equity analysts, reflecting concerns about the company's financial performance and outlook.
	2024-11-12	-4.05 %
Walgreens Boots Alliance (WBA) stock dropped by 4.05% after SpiderRock Advisors LLC reduced its investment stake in the company, alongside a general trend of mixed institutional investor activity and lowered price targets from several analysts amidst ongoing financial challenges reflected in their recent earnings report. Walgreens Boots Alliance (WBA) stock fell by 4.05% following a consensus recommendation of "Reduce" from analysts, alongside several firms lowering their target prices due to concerns over its financial performance and market conditions. Walgreens Boots Alliance (WBA) stock fell by 4.05% due to reduced price targets from multiple analysts indicating concerns over the company's financial performance despite positive quarterly earnings, which has raised doubts about its long-term prospects and led to a cautious sentiment among investors.
	2024-11-11	+3.53 %
Walgreens Boots Alliance (WBA) stock rose by 3.53% following the company's stronger-than-expected quarterly earnings report, which exceeded analyst estimates for both earnings per share and revenue.
	2024-11-05	+3.11 %
Walgreens Boots Alliance (WBA) stock increased by 3.11% following a positive quarterly earnings report, where it exceeded earnings and revenue expectations, and announced a substantial dividend payout.
	2024-11-04	-1.37 %
Walgreens Boots Alliance (WBA) stock declined by 1.37%, which could be attributed to broader economic concerns affecting consumer sentiment and investment, particularly in the context of rising living costs and doubts about financial stability for retirement as highlighted in recent surveys. Walgreens Boots Alliance (WBA) stock decreased by 1.37% due to various factors, including analysts' price target reductions, a negative net margin, and an overall cautious sentiment from investors reflected in recent downgrades to their ratings.
	2024-11-01
The article discusses the recent decline of Walgreens Boots Alliance (WBA) stock, which was reported to be down 0.0% last night, likely due to its recent replacement in the Dow Jones Industrial Average by Amazon, highlighting ongoing challenges in the retail pharmacy industry amid competition and evolving market dynamics.
	2024-10-31	+2.38 %
Walgreens Boots Alliance (WBA) stock rose 2.38% likely due to increased institutional investment and positive earnings results that exceeded analyst expectations, along with a newly announced dividend.
	2024-10-30	-1.18 %
Walgreens Boots Alliance (WBA) stock fell by 1.18% amidst ongoing analyst downgrades and a recent earnings report reflecting significant year-over-year EPS decline, despite a slight revenue increase. The stock's decrease can be attributed to negative sentiment from analysts lowering their price targets and ratings following disappointing financial performance compared to the previous year. Walgreens Boots Alliance (WBA) stock fell by 1.18%, possibly due to its market valuation being surpassed by Trump Media & Technology Group, despite TMTG's ongoing financial struggles and lower revenues. Walgreens Boots Alliance (WBA) stock fell by 1.18% as of last night, likely due to a combination of recent analyst downgrades and adjustments to target prices that suggest a bearish outlook for the company’s stock performance. Walgreens Boots Alliance (WBA) stock fell by 1.18% despite Forsta AP Fonden significantly increasing its stake in the company, likely due to broader market trends or company-specific concerns impacting investor sentiment.
	2024-10-29	-0.95 %
Walgreens Boots Alliance (WBA) stock fell by 0.95% due to reduced institutional interest, as highlighted by Hennion & Walsh Asset Management Inc. decreasing its position by 19.1%, alongside multiple analysts lowering their price targets and ratings for the company's shares. The article discusses the significant rise in the stock value of Trump Media & Technology Group (TMTG), which recently surpassed Walgreens Boots Alliance (WBA), contrasting it with WBA's decline of 0.95%. Walgreens Boots Alliance's stock may be down due to broader market pressures, company-specific issues, or investor sentiment that has shifted towards companies like TMTG that are perceived to have potential for greater volatility and growth tied to political events. The article discusses the valuation of Donald Trump’s Truth Social, which has surpassed that of Elon Musk’s X, while mentioning that Walgreens Boots Alliance (WBA) stock fell by 0.95%. Walgreens Boots Alliance's stock decrease may be attributed to broader market trends or investor sentiment shifts rather than specific news about the company, as the context of the article primarily focuses on the surging value of Trump Media. The article discusses the skyrocketing valuation of Trump Media & Technology Group (TMTG), which has surpassed that of Elon Musk's X Holdings, while mentioning that Walgreens Boots Alliance (WBA) is one of the companies now valued lower than TMTG. The decline in Walgreens Boots Alliance stock, which was down 0.95%, may be attributed to broader market trends or specific company challenges not detailed in the article. The article discusses the significant increase in the valuation of Trump's Truth Social parent company, Trump Media & Technology Group, which is now worth more than Elon Musk's X, amid speculation about Trump's re-election chances, while also noting that Walgreens Boots Alliance's stock was down by 0.95%. The decline in Walgreens Boots Alliance's stock is not directly addressed in the article, but it could be attributed to broader market trends, operational challenges, or investor sentiment affecting the retail and healthcare sectors.
	2024-10-28	+1.94 %
Walgreens Boots Alliance (WBA) stock rose by 1.94% following reports of increased institutional investments and a better-than-expected quarterly earnings performance, which included a revenue increase of 5.9% year-over-year, beating consensus estimates.
	2024-10-25	-0.86 %
Walgreens Boots Alliance (WBA) stock fell by 0.86% due to concerns over increasing competition from tech-driven retailers like Amazon and Walmart in the pharmacy sector, combined with the company's strategic decision to close underperforming stores as it adapts to a changing retail environment. Walgreens Boots Alliance (WBA) stock fell by 0.86% largely due to several brokerages reducing their price targets for the company, including a recent cut from TD Cowen from $16.00 to $14.00, reflecting cautious investor sentiment and impacting the stock’s performance. Walgreens Boots Alliance (WBA) stock declined by 0.86% due to significant share sales by major shareholders, which may create concerns about insider confidence in the stock.

1
500 / page